MyMatrixx Partnering with you to help injured workers on their path to recovery.Powerful, affordable pharmacy solutions for your workers' compensation program.Strong today.Stronger tomorrow.Strongest together. New Branding, Same MyMatrixx PromiseLEARN MORE News October 28, 2024 The Industry Ranks MyMatrixx the #1 PBM (Again) October 2, 2024 Adam Fowler joins MyMatrixx to lead Regulatory Affairs September 6, 2024 Connect with MyMatrixx at NWCDC 2024 July 9, 2024 Connect with MyMatrixx at #WCI2024 April 23, 2024 MyMatrixx Releases 2024 Pharmacy Guidebook Featuring the Top Workers' Compensation Medications Read more Blogs January 30, 2025 Don’t fear pharmacy fraud. Be ready for it. October 10, 2024 National Prescription Drug Take Back Day — Promoting Safety for Injured Workers and Their Families September 26, 2024 The Value of a Comprehensive PBM September 26, 2024 The Lowest Price Doesn’t Always Mean the Greatest Value September 25, 2024 How a PBM Adds Value to the Paper Bill Review Process — Financially and Clinically Read more PharmaWatch February 13, 2025 Symbravo® FDA Approved for Migraine February 13, 2025 Ozempic® FDA Approved for Chronic Kidney Disease February 10, 2025 Journavx™ Approved for Acute Pain January 21, 2025 FDA Recommends Clarifying Label Changes for Transmucosal Buprenorphine Products November 6, 2024 FDA Recalls Over 233000 Bottles of Duloxetine (Cymbalta) The Industry Ranks MyMatrixx the #1 PBM (Again)For the 4th straight year in a row, MyMatrixx has earned the title of best workers’ compensation PBM in CompPharma’s Annual Survey Report.LEARN MORE INFOGRAPHIC: Addressing a Growing Pain Point in Workers' Compensation Learn how our One Drug Review is your remedy and cost saver for topicalsDOWNLOAD NOW
April 23, 2024 MyMatrixx Releases 2024 Pharmacy Guidebook Featuring the Top Workers' Compensation Medications
October 10, 2024 National Prescription Drug Take Back Day — Promoting Safety for Injured Workers and Their Families
September 25, 2024 How a PBM Adds Value to the Paper Bill Review Process — Financially and Clinically
